The endocannibinoid system (ECS) as been connected to numerous different psychological conditions. This study aimed to compile current data from different sources to identify whether or not the ECS would be a good target for medicines to treat or relieve the symptoms of autism spectrum disorders (ASD). If you have read other summaries we’ve written, you’ll have seen the ECS mentioned plenty of times before. Cannabinoids extracted from cannabis, such as CBD and THC, are known to interact with the ECS. This suggests that medical cannabis may play a role in ASD.
Cannabinoids have the potential to positively affect autism. Different interactions with the ECS were able to improve a whole range of ASD related issues. Below is a list of areas positively affected when the ECS was modulated (altered). Although further research involving cannabinoids would be ideal to help clarify how exactly they would help.
Here is the full scientific article if you wish to download it.
It’s important to note that these symptoms were improved, but not removed totally. However, for anyone that has experience of ASD, you’ll know that if we were able to even improve this many aspects of ASD, it would improve the quality of so many lives. So this is an area that deserves a lot of attention.
Further research is needed, especially clinical research performed on humans with the necessary safety and ethical requirements in place, we would be able to begin producing real data that may change the face of medicine as we know it. This article focussed on current research, and due to limitations, the majority of research is on animal models. There is a lot of anecdotal information available. Unfortunately no matter how convincing and obvious the results may be, it’s hard to use this data. With more funding for independent studies, we would have results and progress much faster.